Đang chuẩn bị liên kết để tải về tài liệu:
Bevacizumab for metachronous metastatic colorectal cancer: A reflection of community based practice

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since these studies are lacking for patients with metachronous metastases, the aim of this study is to evaluate the current role of bevacizumab in the treatment of metachronous metastases of CRC. |